Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO). (Q42242966)
Jump to navigation
Jump to search
scientific article published on 16 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO). |
scientific article published on 16 January 2014 |
Statements
1 reference
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO). (English)
1 reference
Somnuek Sungkanuparph
1 reference
Chloe Orkin
1 reference
David A Wohl
1 reference
Manuela Doroana
1 reference
José H Pilotto
1 reference
Patrick Yeni
1 reference
Simon Vanveggel
1 reference
Henri Deckx
1 reference
Katia Boven
1 reference
16 January 2014
1 reference
1 reference
Identifiers
1 reference